Deep Lens has extended one of the world’s first and best known digital pathology cloud platforms that for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types.
Based on feedback from hundreds of expert global users, we have enhanced the system to include AI-powered image detection and workflow support, collaboration, cloud storage and
Deep Lens VIPER, used at major institutions around the world, is able to help care teams identify and triage patients for clinical trials much sooner than traditional methods. By utilizing VIPER, qualified patients are found at the time of diagnosis. The result? Patients receive the right treatment for the right patient at the right time.
Pharma and biotech work with Deep Lens because machine vision in pathology is an important component to reach their translational research objectives.
Tumor identification and classification in pathology images help drive understanding of longitudinal patient outcomes.
Deep Lens has extended one of the world’s first digital pathology cloud platforms that for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types.
Learn MorePharmaceutical and biotech companies turn to Deep Lens because the answers require more than just sequence and EMR data, but rely on the anatomy of the disease as well. For the first time ever, use real time pathology data to go "upstream" of the oncologist and identify patients at the time of diagnosis. Find more patients and shorten trial duration.
Learn MoreDeep Lens Inc.,
1275 Kinnear Rd,
Columbus, OH 43212
